Personalis, AstraZeneca Extend Collaboration Around Residual Cancer Detection Test
Personalis will use its NeXT Personal molecular residual disease assay to track emerging recurrence in at least one AstraZeneca drug trial.
AACC Issues New Cervical Cancer Detection Guidance
The new guidance includes an ideal lab report template and synthesizes guidelines previously issued by three other organizations.
Fujirebio Europe to Distribute Self-Screen Cervical Cancer Test
The test is designed to detect elevated methylation levels of cervical cancer biomarkers and may be used as a triage follow-up test of HPV-positive women.
Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval
The GynTect assay detects oncogenic DNA methylation markers from cervical smear samples following abnormal cancer-screen findings.
The self-administered Sheba-HPV test can be ordered online and sent to laboratories via company-owned drop boxes.
Oct 28, 2021
Mar 16, 2021
Jan 30, 2020
Aug 30, 2019
Jul 29, 2019
Jul 11, 2019
Cancer Detection Firm StageZero Raises C$2.7M
Jun 12, 2019